iRadimed (iRadimed) Operating Cash Flow per Share : $1.00 (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is iRadimed Operating Cash Flow per Share?

iRadimed's operating cash flow per share for the three months ended in Mar. 2024 was $0.31. iRadimed's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $1.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of iRadimed was -5.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 9.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for iRadimed's Operating Cash Flow per Share or its related term are showing as below:

IRMD' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -1.6 Med: 15.45 Max: 76.7
Current: 31.2

During the past 12 years, iRadimed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 76.70% per year. The lowest was -1.60% per year. And the median was 15.45% per year.

IRMD's 3-Year OCF Growth Rate is ranked better than
83.55% of 687 companies
in the Medical Devices & Instruments industry
Industry Median: 2.5 vs IRMD: 31.20

iRadimed Operating Cash Flow per Share Historical Data

The historical data trend for iRadimed's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Operating Cash Flow per Share Chart

iRadimed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.83

0.47

0.89

0.80

1.06

iRadimed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.37	0.28	0.11	0.31	0.31

Competitive Comparison of iRadimed's Operating Cash Flow per Share

For the Medical Devices subindustry, iRadimed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iRadimed's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where iRadimed's Price-to-Operating-Cash-Flow falls into.

iRadimed Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

iRadimed's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	13.465	/	12.723
	=	1.06

iRadimed's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	3.883	/	12.750
	=	0.30

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.00

iRadimed Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of iRadimed's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

iRadimed (iRadimed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (NAS:IRMD) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

46K:Germany

Address

1025 Willa Springs Drive, Winter Springs, FL, USA, 32708

Website

https://www.iradimed.com

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.

Executives

Roger E. Susi	director, 10 percent owner, officer: CEO, President, Chairman	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
James B Hawkins	director	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Anthony Vuoto	director
Monty K Allen	director
Hilda Frederique Scharen-guivel	director	440 PALM ISLAND SE, CLEARWATER BEACH FL 33767
John Glenn	officer: Chief Financial Officer	7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Christopher K. Scott	officer: CHIEF FINANCIAL OFFICER & SECR	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Brent Johnson	officer: Exec. VP. Sales & Marketing	4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588
Steven M. Nardi	officer: VP MANUFACTURING	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Louis S. Waldman	officer: CONTROLLER	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Leslie L Mcdonnell	director, officer: Chief Exec Officer & Director	1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Francis X. Casey	officer: VP OF REG AND QUAL ASSURANCE	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
John K Mccreery	officer: Chief Operating Officer	IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708
Jonathan Kennedy	director	INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Serge Novovich	director	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708